Insulbox Refractory Cement

Product Description

Insulbox Refractory Cement was a high-temperature insulating and bonding cement manufactured by Quigley Company, Inc., a New York-based specialty materials manufacturer that operated throughout much of the twentieth century. The product was designed to withstand extreme thermal conditions in industrial settings, making it a common material wherever heat containment, fireproofing, or refractory lining work was required.

Refractory cements of this type were engineered to bond, seal, and insulate surfaces exposed to sustained high temperatures—including furnace walls, boiler chambers, kilns, industrial ovens, and high-pressure pipe systems. Insulbox was marketed as a ready-to-use or mixed-on-site cementitious compound suitable for patching, setting, and coating refractory brickwork and pipe insulation assemblies. Its application spanned heavy manufacturing, petrochemical refining, steel production, power generation, and shipbuilding environments.

Quigley Company built a substantial product line around refractory and specialty insulating materials throughout the mid-twentieth century. Insulbox Refractory Cement was one of several Quigley-branded products that became the subject of asbestos litigation as occupational health research documented the dangers of asbestos-containing construction and industrial materials. Quigley itself eventually faced significant asbestos liability arising from its broader product catalog and its corporate relationship with Pfizer Inc., which had acquired the company.


Asbestos Content

Insulbox Refractory Cement, consistent with industry-standard refractory cement formulations of its era, is alleged in litigation records to have contained asbestos fibers as a functional component of its composition. Asbestos was widely incorporated into refractory and insulating cements during the mid-twentieth century because its physical properties—thermal resistance, tensile reinforcement, and resistance to chemical breakdown—made it an effective additive for products intended to perform under extreme heat.

In refractory applications, asbestos fibers served as a reinforcing matrix within the cement binder, helping the cured material resist cracking under thermal cycling and mechanical stress. Chrysotile (white asbestos) was the most commonly used fiber type in such formulations, though litigation records in cases involving Quigley products have alleged the presence of asbestos content in the company’s refractory and insulating cement lines broadly.

The asbestos content of refractory cements like Insulbox was typically bound within the cured product under normal conditions. However, as documented in occupational health and regulatory research, the mixing, application, cutting, grinding, removal, and disturbance of asbestos-containing cements could release respirable fibers into the surrounding work environment—creating inhalation hazards for workers who handled or worked in proximity to these materials.


How Workers Were Exposed

Industrial workers across a range of trades and facilities are documented in litigation records as having encountered Insulbox Refractory Cement in the course of their employment. Because refractory cements were applied throughout heavy industrial infrastructure, exposure was not limited to a single trade or job classification. Plaintiffs in asbestos litigation involving Quigley products alleged exposure during the routine use of Insulbox in a variety of occupational contexts.

Mixing and Application: Workers who mixed powdered or paste-form refractory cement by hand or with mechanical mixers could disturb asbestos fibers during the blending process. Troweling, packing, and spreading the cement onto furnace walls, boiler casings, or pipe fittings similarly created opportunities for fiber release in work areas that were often poorly ventilated.

Cutting and Fitting: In industrial pipe insulation work, refractory cements were used to set and seal insulating sections around high-temperature pipes. Workers who cut, shaped, or trimmed cured or partially cured cement encountered friable material that could release asbestos fibers.

Maintenance and Demolition: Refractory linings and insulation assemblies required periodic inspection, repair, and replacement. Workers tasked with chipping out old refractory cement, breaking apart deteriorated pipe insulation sections, or preparing surfaces for reapplication faced potentially heavy exposure to airborne fibers released from disturbed material.

Bystander Exposure: Litigation records also document claims from workers who did not personally apply Insulbox or similar refractory cements but who worked in close proximity to those who did. In confined industrial environments—engine rooms, boiler rooms, furnace areas, and refinery units—asbestos fibers released during application or disturbance could remain suspended in the air and affect nearby workers.

Facility Types: Plaintiffs alleging exposure to Insulbox Refractory Cement have included workers from industrial manufacturing plants, oil refineries, power stations, steel mills, and shipyard facilities—environments where refractory materials were integral to ongoing operations and where Quigley products were documented as regularly supplied.

The occupational exposure risks associated with asbestos-containing refractory cements are recognized under OSHA’s asbestos standards (29 CFR 1910.1001 for general industry and 29 CFR 1926.1101 for construction), which establish permissible exposure limits and mandate engineering controls, respiratory protection, and medical surveillance for workers who may encounter asbestos-containing materials during their work.


Insulbox Refractory Cement is classified as a Tier 2 litigated product. Unlike manufacturers that resolved their asbestos liabilities through Chapter 11 bankruptcy reorganization and the establishment of a Section 524(g) asbestos trust fund, Quigley’s situation involved a complex legal history that unfolded over many years through both bankruptcy proceedings and active tort litigation.

Quigley Company and Pfizer: Quigley Company, Inc. filed for Chapter 11 bankruptcy protection in 2004 in connection with its asbestos liability. Because Quigley had been a wholly owned subsidiary of Pfizer Inc. since 1968, its bankruptcy proceedings attracted considerable attention and were the subject of prolonged litigation involving Pfizer’s potential contribution to any settlement. The Quigley bankruptcy case proceeded through the United States Bankruptcy Court for the Southern District of New York over many years before a reorganization plan was ultimately confirmed.

Litigation Framing: Plaintiffs alleged that Quigley Company was aware, or should have been aware, of the hazards posed by asbestos-containing products including its refractory cement lines, and that the company failed to adequately warn workers of those risks. Litigation records document claims from workers diagnosed with asbestos-related diseases including mesothelioma, asbestos-related lung cancer, asbestosis, and pleural disease who alleged occupational exposure to Quigley-manufactured products.

Legal Options for Injured Workers: Individuals who were exposed to Insulbox Refractory Cement or other Quigley refractory products and who have received a diagnosis of an asbestos-related disease should consult with a qualified asbestos attorney to evaluate the legal options available under the Quigley reorganization outcome and any applicable litigation avenues. Because multiple manufacturers often supplied refractory and insulating materials to the same worksites, additional claims against other responsible parties—including other trust funds or solvent defendants—may also be available.

Relevant diagnoses for potential legal claims include:

  • Mesothelioma (pleural, peritoneal, or pericardial)
  • Asbestos-related lung cancer
  • Asbestosis
  • Pleural plaques or diffuse pleural thickening

Workers and family members of deceased workers who were employed in industries where Insulbox Refractory Cement was used are encouraged to document their occupational history thoroughly, including employers, job sites, dates of employment, and any known product names encountered during their careers. This documentation is critical to supporting claims under any applicable legal remedy.


This article is provided for informational and reference purposes only and does not constitute legal advice. Individuals seeking legal assistance regarding asbestos exposure should consult a licensed attorney with experience in asbestos litigation.